aTyr Pharma Changes Nasdaq Ticker from "LIFE" to "ATYR"

SAN DIEGO, June 3, 2024 – aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical-stage biotechnology company focused on innovative medicines derived from its unique tRNA synthetase platform, today announced a significant change in its stock market identity. The company will be changing its ticker symbol from "LIFE" to "ATYR" effective at the market opening on June 5, 2024. This transition aims to better represent the company’s corporate identity and enhance its visibility among stakeholders.

Dr. Sanjay S. Shukla, President and CEO of aTyr, emphasized the importance of this change as the company progresses with its lead therapeutic candidate, efzofitimod. Currently, efzofitimod is undergoing a pivotal Phase 3 clinical trial for pulmonary sarcoidosis, a serious lung disease characterized by inflammation and scarring. As aTyr prepares for potential commercialization of efzofitimod, the new ticker symbol “ATYR” is intended to strengthen the company’s market presence.

Existing stockholders are not required to take any action concerning the ticker symbol change. The company’s common stock will remain listed on the Nasdaq Capital Market, and the CUSIP number will stay the same.

aTyr Pharma operates at the forefront of biotechnology, leveraging the evolutionary knowledge of tRNA synthetase biology to develop novel therapies for fibrosis and inflammation. tRNA synthetases are ancient proteins with essential roles in human biology, and aTyr's platform focuses on uncovering new therapeutic pathways by exploring the diverse functions of these proteins. Efzofitimod, the company's lead candidate, is a pioneering biologic immunomodulator aimed at treating interstitial lung disease, a group of conditions that lead to lung inflammation and fibrosis.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!